Selected research
Industry Research
Biomanufacturing and Fermentation Service Industry Research Report 2026
Market perspective
The global Biomanufacturing and Fermentation Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biomanufacturing and Fermentation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biomanufacturing and Fermentation Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biomanufacturing and Fermentation Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biomanufacturing and Fermentation Service include FUJIFILM Biotechnologies, Elise Biopharma, BOC Sciences, Isomerase Therapeutics, AGC Biologics, Centre for Process Innovation (CPI), Euroapi, 3PBIOVIAN and Abolis Biotechnologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biomanufacturing and Fermentation Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biomanufacturing and Fermentation Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomanufacturing and Fermentation Service Market by Company
FUJIFILM Biotechnologies
Elise Biopharma
BOC Sciences
Isomerase Therapeutics
AGC Biologics
Centre for Process Innovation (CPI)
Euroapi
3PBIOVIAN
Abolis Biotechnologies
Evonik
ScaleUp Bio Pte Ltd
Olon Biotech
Biocatalysts Ltd
Manus Bio
ADM
Bio‑Technical Resources
GEA
Lonza
WuXi Biologics
Ajinomoto
BIOVECTRA Inc.
Nordmark Pharma GmbH
Dakota BioWorx
Andgel Industrial (Shanghai) Co
Chengdu Yingde Biomedical
Thermo Fisher Scientific
Asymchem
Danaher
Sartorius
Laurus Bio
Biomanufacturing and Fermentation Service Segment by Type
Strain Engineering Services
Fermentation Process Optimization
Analytical Testing & Quality Control Services
Fermentation CDMO Service
Biomanufacturing and Fermentation Service Segment by Application
Biopharmaceuticals
Industrial Biotechnology
Food and Functional Ingredients
Others
Biomanufacturing and Fermentation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomanufacturing and Fermentation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomanufacturing and Fermentation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomanufacturing and Fermentation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomanufacturing and Fermentation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Strain Engineering Services
- Fermentation Process Optimization
- Analytical Testing & Quality Control Services
- Fermentation CDMO Service
Applications
- Biopharmaceuticals
- Industrial Biotechnology
- Food and Functional Ingredients
- Others
Companies covered
- FUJIFILM Biotechnologies
- Elise Biopharma
- BOC Sciences
- Isomerase Therapeutics
- AGC Biologics
- Centre for Process Innovation (CPI)
- Euroapi
- 3PBIOVIAN
- Abolis Biotechnologies
- Evonik
- ScaleUp Bio Pte Ltd
- Olon Biotech
- Biocatalysts Ltd
- Manus Bio
- ADM
- Bio‑Technical Resources
- GEA
- Lonza
- WuXi Biologics
- Ajinomoto
- BIOVECTRA Inc.
- Nordmark Pharma GmbH
- Dakota BioWorx
- Andgel Industrial (Shanghai) Co
- Chengdu Yingde Biomedical
- Thermo Fisher Scientific
- Asymchem
- Danaher
- Sartorius
- Laurus Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomanufacturing and Fermentation Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Strain Engineering Services
- 2.2.3 Fermentation Process Optimization
- 2.2.4 Analytical Testing & Quality Control Services
- 2.2.5 Fermentation CDMO Service
- 2.3 Biomanufacturing and Fermentation Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceuticals
- 2.3.3 Industrial Biotechnology
- 2.3.4 Food and Functional Ingredients
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Biomanufacturing and Fermentation Service Breakdown Data by Type
- 3.1 Global Biomanufacturing and Fermentation Service Historic Market Size by Type (2021-2026)
- 3.2 Global Biomanufacturing and Fermentation Service Forecasted Market Size by Type (2027-2032)
4 Biomanufacturing and Fermentation Service Breakdown Data by Application
- 4.1 Global Biomanufacturing and Fermentation Service Historic Market Size by Application (2021-2026)
- 4.2 Global Biomanufacturing and Fermentation Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biomanufacturing and Fermentation Service Market Perspective (2021-2032)
- 5.2 Global Biomanufacturing and Fermentation Service Growth Trends by Region
- 5.2.1 Global Biomanufacturing and Fermentation Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biomanufacturing and Fermentation Service Historic Market Size by Region (2021-2026)
- 5.2.3 Biomanufacturing and Fermentation Service Forecasted Market Size by Region (2027-2032)
- 5.3 Biomanufacturing and Fermentation Service Market Dynamics
- 5.3.1 Biomanufacturing and Fermentation Service Industry Trends
- 5.3.2 Biomanufacturing and Fermentation Service Market Drivers
- 5.3.3 Biomanufacturing and Fermentation Service Market Challenges
- 5.3.4 Biomanufacturing and Fermentation Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biomanufacturing and Fermentation Service Players by Revenue
- 6.1.1 Global Top Biomanufacturing and Fermentation Service Players by Revenue (2021-2026)
- 6.1.2 Global Biomanufacturing and Fermentation Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Biomanufacturing and Fermentation Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biomanufacturing and Fermentation Service Head Office and Area Served
- 6.4 Global Biomanufacturing and Fermentation Service Players, Product Type & Application
- 6.5 Global Biomanufacturing and Fermentation Service Manufacturers Established Date
- 6.6 Global Biomanufacturing and Fermentation Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biomanufacturing and Fermentation Service Market Size (2021-2032)
- 7.2 North America Biomanufacturing and Fermentation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biomanufacturing and Fermentation Service Market Size by Country (2021-2026)
- 7.4 North America Biomanufacturing and Fermentation Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biomanufacturing and Fermentation Service Market Size (2021-2032)
- 8.2 Europe Biomanufacturing and Fermentation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biomanufacturing and Fermentation Service Market Size by Country (2021-2026)
- 8.4 Europe Biomanufacturing and Fermentation Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biomanufacturing and Fermentation Service Market Size (2021-2032)
- 9.2 Asia-Pacific Biomanufacturing and Fermentation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biomanufacturing and Fermentation Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biomanufacturing and Fermentation Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biomanufacturing and Fermentation Service Market Size (2021-2032)
- 10.2 South America Biomanufacturing and Fermentation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biomanufacturing and Fermentation Service Market Size by Country (2021-2026)
- 10.4 South America Biomanufacturing and Fermentation Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biomanufacturing and Fermentation Service Market Size (2021-2032)
- 11.2 Middle East & Africa Biomanufacturing and Fermentation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biomanufacturing and Fermentation Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biomanufacturing and Fermentation Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 FUJIFILM Biotechnologies
- 12.1.1 FUJIFILM Biotechnologies Company Information
- 12.1.2 FUJIFILM Biotechnologies Business Overview
- 12.1.3 FUJIFILM Biotechnologies Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.1.4 FUJIFILM Biotechnologies Biomanufacturing and Fermentation Service Product Portfolio
- 12.1.5 FUJIFILM Biotechnologies Recent Developments
- 12.2 Elise Biopharma
- 12.2.1 Elise Biopharma Company Information
- 12.2.2 Elise Biopharma Business Overview
- 12.2.3 Elise Biopharma Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.2.4 Elise Biopharma Biomanufacturing and Fermentation Service Product Portfolio
- 12.2.5 Elise Biopharma Recent Developments
- 12.3 BOC Sciences
- 12.3.1 BOC Sciences Company Information
- 12.3.2 BOC Sciences Business Overview
- 12.3.3 BOC Sciences Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.3.4 BOC Sciences Biomanufacturing and Fermentation Service Product Portfolio
- 12.3.5 BOC Sciences Recent Developments
- 12.4 Isomerase Therapeutics
- 12.4.1 Isomerase Therapeutics Company Information
- 12.4.2 Isomerase Therapeutics Business Overview
- 12.4.3 Isomerase Therapeutics Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.4.4 Isomerase Therapeutics Biomanufacturing and Fermentation Service Product Portfolio
- 12.4.5 Isomerase Therapeutics Recent Developments
- 12.5 AGC Biologics
- 12.5.1 AGC Biologics Company Information
- 12.5.2 AGC Biologics Business Overview
- 12.5.3 AGC Biologics Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.5.4 AGC Biologics Biomanufacturing and Fermentation Service Product Portfolio
- 12.5.5 AGC Biologics Recent Developments
- 12.6 Centre for Process Innovation (CPI)
- 12.6.1 Centre for Process Innovation (CPI) Company Information
- 12.6.2 Centre for Process Innovation (CPI) Business Overview
- 12.6.3 Centre for Process Innovation (CPI) Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.6.4 Centre for Process Innovation (CPI) Biomanufacturing and Fermentation Service Product Portfolio
- 12.6.5 Centre for Process Innovation (CPI) Recent Developments
- 12.7 Euroapi
- 12.7.1 Euroapi Company Information
- 12.7.2 Euroapi Business Overview
- 12.7.3 Euroapi Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.7.4 Euroapi Biomanufacturing and Fermentation Service Product Portfolio
- 12.7.5 Euroapi Recent Developments
- 12.8 3PBIOVIAN
- 12.8.1 3PBIOVIAN Company Information
- 12.8.2 3PBIOVIAN Business Overview
- 12.8.3 3PBIOVIAN Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.8.4 3PBIOVIAN Biomanufacturing and Fermentation Service Product Portfolio
- 12.8.5 3PBIOVIAN Recent Developments
- 12.9 Abolis Biotechnologies
- 12.9.1 Abolis Biotechnologies Company Information
- 12.9.2 Abolis Biotechnologies Business Overview
- 12.9.3 Abolis Biotechnologies Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.9.4 Abolis Biotechnologies Biomanufacturing and Fermentation Service Product Portfolio
- 12.9.5 Abolis Biotechnologies Recent Developments
- 12.10 Evonik
- 12.10.1 Evonik Company Information
- 12.10.2 Evonik Business Overview
- 12.10.3 Evonik Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.10.4 Evonik Biomanufacturing and Fermentation Service Product Portfolio
- 12.10.5 Evonik Recent Developments
- 12.11 ScaleUp Bio Pte Ltd
- 12.11.1 ScaleUp Bio Pte Ltd Company Information
- 12.11.2 ScaleUp Bio Pte Ltd Business Overview
- 12.11.3 ScaleUp Bio Pte Ltd Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.11.4 ScaleUp Bio Pte Ltd Biomanufacturing and Fermentation Service Product Portfolio
- 12.11.5 ScaleUp Bio Pte Ltd Recent Developments
- 12.12 Olon Biotech
- 12.12.1 Olon Biotech Company Information
- 12.12.2 Olon Biotech Business Overview
- 12.12.3 Olon Biotech Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.12.4 Olon Biotech Biomanufacturing and Fermentation Service Product Portfolio
- 12.12.5 Olon Biotech Recent Developments
- 12.13 Biocatalysts Ltd
- 12.13.1 Biocatalysts Ltd Company Information
- 12.13.2 Biocatalysts Ltd Business Overview
- 12.13.3 Biocatalysts Ltd Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.13.4 Biocatalysts Ltd Biomanufacturing and Fermentation Service Product Portfolio
- 12.13.5 Biocatalysts Ltd Recent Developments
- 12.14 Manus Bio
- 12.14.1 Manus Bio Company Information
- 12.14.2 Manus Bio Business Overview
- 12.14.3 Manus Bio Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.14.4 Manus Bio Biomanufacturing and Fermentation Service Product Portfolio
- 12.14.5 Manus Bio Recent Developments
- 12.15 ADM
- 12.15.1 ADM Company Information
- 12.15.2 ADM Business Overview
- 12.15.3 ADM Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.15.4 ADM Biomanufacturing and Fermentation Service Product Portfolio
- 12.15.5 ADM Recent Developments
- 12.16 Bio‑Technical Resources
- 12.16.1 Bio‑Technical Resources Company Information
- 12.16.2 Bio‑Technical Resources Business Overview
- 12.16.3 Bio‑Technical Resources Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.16.4 Bio‑Technical Resources Biomanufacturing and Fermentation Service Product Portfolio
- 12.16.5 Bio‑Technical Resources Recent Developments
- 12.17 GEA
- 12.17.1 GEA Company Information
- 12.17.2 GEA Business Overview
- 12.17.3 GEA Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.17.4 GEA Biomanufacturing and Fermentation Service Product Portfolio
- 12.17.5 GEA Recent Developments
- 12.18 Lonza
- 12.18.1 Lonza Company Information
- 12.18.2 Lonza Business Overview
- 12.18.3 Lonza Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.18.4 Lonza Biomanufacturing and Fermentation Service Product Portfolio
- 12.18.5 Lonza Recent Developments
- 12.19 WuXi Biologics
- 12.19.1 WuXi Biologics Company Information
- 12.19.2 WuXi Biologics Business Overview
- 12.19.3 WuXi Biologics Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.19.4 WuXi Biologics Biomanufacturing and Fermentation Service Product Portfolio
- 12.19.5 WuXi Biologics Recent Developments
- 12.20 Ajinomoto
- 12.20.1 Ajinomoto Company Information
- 12.20.2 Ajinomoto Business Overview
- 12.20.3 Ajinomoto Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.20.4 Ajinomoto Biomanufacturing and Fermentation Service Product Portfolio
- 12.20.5 Ajinomoto Recent Developments
- 12.21 BIOVECTRA Inc.
- 12.21.1 BIOVECTRA Inc. Company Information
- 12.21.2 BIOVECTRA Inc. Business Overview
- 12.21.3 BIOVECTRA Inc. Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.21.4 BIOVECTRA Inc. Biomanufacturing and Fermentation Service Product Portfolio
- 12.21.5 BIOVECTRA Inc. Recent Developments
- 12.22 Nordmark Pharma GmbH
- 12.22.1 Nordmark Pharma GmbH Company Information
- 12.22.2 Nordmark Pharma GmbH Business Overview
- 12.22.3 Nordmark Pharma GmbH Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.22.4 Nordmark Pharma GmbH Biomanufacturing and Fermentation Service Product Portfolio
- 12.22.5 Nordmark Pharma GmbH Recent Developments
- 12.23 Dakota BioWorx
- 12.23.1 Dakota BioWorx Company Information
- 12.23.2 Dakota BioWorx Business Overview
- 12.23.3 Dakota BioWorx Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.23.4 Dakota BioWorx Biomanufacturing and Fermentation Service Product Portfolio
- 12.23.5 Dakota BioWorx Recent Developments
- 12.24 Andgel Industrial (Shanghai) Co
- 12.24.1 Andgel Industrial (Shanghai) Co Company Information
- 12.24.2 Andgel Industrial (Shanghai) Co Business Overview
- 12.24.3 Andgel Industrial (Shanghai) Co Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.24.4 Andgel Industrial (Shanghai) Co Biomanufacturing and Fermentation Service Product Portfolio
- 12.24.5 Andgel Industrial (Shanghai) Co Recent Developments
- 12.25 Chengdu Yingde Biomedical
- 12.25.1 Chengdu Yingde Biomedical Company Information
- 12.25.2 Chengdu Yingde Biomedical Business Overview
- 12.25.3 Chengdu Yingde Biomedical Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.25.4 Chengdu Yingde Biomedical Biomanufacturing and Fermentation Service Product Portfolio
- 12.25.5 Chengdu Yingde Biomedical Recent Developments
- 12.26 Thermo Fisher Scientific
- 12.26.1 Thermo Fisher Scientific Company Information
- 12.26.2 Thermo Fisher Scientific Business Overview
- 12.26.3 Thermo Fisher Scientific Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.26.4 Thermo Fisher Scientific Biomanufacturing and Fermentation Service Product Portfolio
- 12.26.5 Thermo Fisher Scientific Recent Developments
- 12.27 Asymchem
- 12.27.1 Asymchem Company Information
- 12.27.2 Asymchem Business Overview
- 12.27.3 Asymchem Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.27.4 Asymchem Biomanufacturing and Fermentation Service Product Portfolio
- 12.27.5 Asymchem Recent Developments
- 12.28 Danaher
- 12.28.1 Danaher Company Information
- 12.28.2 Danaher Business Overview
- 12.28.3 Danaher Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.28.4 Danaher Biomanufacturing and Fermentation Service Product Portfolio
- 12.28.5 Danaher Recent Developments
- 12.29 Sartorius
- 12.29.1 Sartorius Company Information
- 12.29.2 Sartorius Business Overview
- 12.29.3 Sartorius Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.29.4 Sartorius Biomanufacturing and Fermentation Service Product Portfolio
- 12.29.5 Sartorius Recent Developments
- 12.30 Laurus Bio
- 12.30.1 Laurus Bio Company Information
- 12.30.2 Laurus Bio Business Overview
- 12.30.3 Laurus Bio Revenue in Biomanufacturing and Fermentation Service Business (2021-2026)
- 12.30.4 Laurus Bio Biomanufacturing and Fermentation Service Product Portfolio
- 12.30.5 Laurus Bio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst